The BIA, BioCentury and the China-Britain Business Council are delighted to bring you the next in our series of updates on opportunities in China for UK biotechs. This update will focus on recent policy and regulatory reforms in China that impact biopharma innovation, and which may create new cross-border strategies for UK companies. A panel of experts will present on their viewpoint of these changes, followed by a chance for Q&A and a full panel discussion.
